The Legal and Institutional Framework of Market Surveillance and the Fight against Spurious, Falsely Labelled, Falsified or Counterfeit Product in West Africa: The Case of Togo
Abstract
The worsening of the phenomenon of the circulation of spurious, falsely-labelled, falsified or counterfeit product (SFFC) in the world has prompted several African countries to take part in a number of international initiatives and to develop national strategies. Although often unknown to the general public, in Togo, there are institutions and bodies in charge of regulation, and a legal framework for the control and monitoring of the drug market. The law n°2009-007 of May 15, 2009 on the public health code and the law n°2015-10 of November 24, 2015 on the penal code are the main legal instruments that allow, in addition to the international conventions to which Togo is a party, to define the legal framework, the qualification of the offences and the sanctions applicable in the context of such offences. While the definitions and sanctions imposed may be diverse, the penal code remains the most specific text incriminating offenses in the context of PMQIF.
Downloads
References
2. WHO. Presentation of the WHO to French Public Institutions and other operators: The work of the WHO to combat substandard and falsified medical products [Internet]. 2018 Dec 13. [cited 2022 Mar 10]. Available from:
http://remed.org/wp-content/uploads/2019/08/Travail-de-lOMS-sur-les-produits-medicaux-SF_presentations-Paris-Dec-2018.pdf
3. UNDOCS. Report of the Conference of the Parties to the United Nations Convention against Transnational Organized Crime at its fifth session, held in Vienna from 18 to 22 October 2010 [Internet]. CTOC/COP/2010/17; 2010. [cited 2022 Mar 10]. Available from:
https://www.unodc.org/documents/treaties/UNTOC/Publications/TOC%20Convention/TOCebook-e.pdf
4. United Nations convention against transnational organized crime and related protocols;2000 Nov 15.
5. United Nations Treaty Collection [Internet]. [cited 2022 Mar 16]. Available from:
https://treaties.un.org/pages/ViewDetails.aspx?src=IND&mtdsg_no=XVIII-12&chapter=18&clang=_en
6. Council of Europe. Council of Europe Convention on the counterfeiting of medical products and similar crimes involving threats to public health [Internet]. Moscow; 2011. [cited 2022 Mar 16]. Available from:
https://rm.coe.int/1680084841
7. The MEDICRIME Convention | EDQM - European Directorate for the Quality of Medicines [Internet]. [cited 2022 Mar 16]. Available from:
https://www.edqm.eu/fr/convention-medicrime-1470.html
8. WHO. Regional strategy on the regulation of medical products in the African region, 2016-2025; 2016.
9. African Union. African union model law on the regulation of medical products; 2016
10. Explanatory Note African Union and Nations Model Law on the Regulation of Medical Products: Increasing Access to New Health Technologies and their Deployment to Patients in Need. Explanatory note: African Union and Nations Model Law on the Regulation of Medical Products: Increasing Access to New Health Technologies and their Deployment to Patients in Need [Internet]. [cited 2022 Apr 03]. Available from:
https://adphealth.org/upload/resource/French_Issue_Brief_on_AU_Model_Law.pdf
11. Vidjro S, Fatima, Kampadilemba, Anne Cinthia, Antoine Serge, Jean-Yves. La régulation du secteur pharmaceutique dans l’espace UEMOA : des législations nationales vers un cadre juridique communautaire à fort impact. JATPB [Internet]. 2022 Oct. 21 [cited 2022 Dec. 27];1(1):27-36. Available from:
https://soapgi-jatpb.org/index.php/jatpb/article/view/4.
12. Ministry of Health and Social Protection TOGO. National Health Development Plan 2017-2022.
13. Ministry of Health TOGO. Order No. 0021/2013/MS/CAB/SG on the organization of the services of the Ministry of Health; 2013 Feb 27.
14. Ministry of Health and Public Hygiene, TOGO. Order No. 207/2020/MSHP/CAB/SG/DGAS/DPML establishing, organizing and operating the National Medicines Quality Control Laboratory (LNCQM); 2020 July 14.
15. The President of the Togolese Republic. Decree No. 2016-017/PR, relating to the attributions, organization and functioning of the Togolese Revenue Office. (OTR); 2016 Feb 18
16. The President of the Togolese Republic. Decree No. 2004/053 of January 28, 2004 establishing and assigning the Central Office for the Repression of Illicit Drug Trafficking and Money Laundering; 2004 Mar 18.
17. RTG. Over 8 tonnes of drugs seized in 2021 [Internet]. Official site of Togo, Togolese Republic. [cited 2022 Aug 15]. Available from:
https://www.republiquetogolaise.com/securite/0404-6749-plus-de-8-tonnes-de-drogues-saisies-en-2021
18. The President of the Togolese Republic. Decree No. 096/040/PR of April 10, 1996, establishing the National Anti-Drug Commission; 1996 Jun 26.
19. Emmanuel Atcha. Togo: seizure of 85 tons of fake medicines [Internet]. Africa Tribune. [cited 2022 Aug 15] Available from:
https://afrique.latribune.fr/politique/politique-publique/2018-11-16/togo-saisie-de-85-tonnes-de-faux-medicaments-797650.html
20. The President of the Togolese Republic. Law 98-008 on drug control; 1998 Mar 15.
21. National Assembly. Framework law N°2001-002 of January 23, 2001 on medicine and pharmacy; 2001 Jan 23.
22. Togolese Republic. Law No. 2009-007 of May 15, 2009 on the public health code of the Togolese Republic; 2009.
23. Togolese Republic. Law No. 2015-10 of November 24, 2015 on the new penal code; 2015 Nov 24.
24. Togolese Republic. Law No. 2018-007 on the national customs code; 2018 Jun 25.
25. WHO Bulletin WHO [Internet]. Vol71 1993; [cited 2022 Apr 03]. Available from:
https://apps.who.int/iris/bitstream/handle/10665/261677/PMC2393512.pdf
26. WHO. Sixty-third World Health Assembly. WHA63/2010/REC/1; 2010 May 17.
27. Report by the Director-General. 70th World Health Assembly. Member State mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit medical products. A70/23. sect. Appendix 3; 2017 Mar 20.p.33-36.
28. Nicholas Molfessis. Combat legal insecurity or the struggle of the legal system against itself. article annexed to the annual study of the Council of State of 2006, op cit. 2006;392.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
